Your browser (Internet Explorer 7 or lower) is out of date. It has known security flaws and may not display all features of this and other websites. Learn how to update your browser.


Navigate / search

The Evolution of Tumors from Cells with Inherited p53 Mutations in Humans and Mice

Event Start Date: 
Tuesday, January 12, 2016 - 12:00pm
Event End Date: 
Tuesday, January 12, 2016 - 1:00pm

A world-renowned cancer biologist, Dr. Levine is best known for his 1979 discovery of the tumor suppressor gene p53, a molecule that inhibits tumor development. His group elucidated the functions of this gene and its role in viral mediated cancers, and his research has fueled the design of a new generation of anti-cancer therapies.

Dr. Levine’s current research focuses on studying the relationship between p53 mutations and breast cancer stem cells. Using RNA microarrays, he identified the stem cell signatures of breast cancers with p53 mutations. These observations have been confirmed with several other cancers as well. He is currently developing a diagnostic tool to identify breast cancers with poor prognostic outcome. This may serve as a biomarker and help identify appropriate drug treatments for a specific tumor.


Belfer Research Building

413 East 69th Street (between First and York Avenues)

2nd Floor Conference Room

New York, NY  10065

Contact person and information for event: 

Denise Charles